Next Article in Journal
Widefield Swept Source OCTA in Retinitis Pigmentosa
Previous Article in Journal
High Genetic Diversity and No Evidence of Clonal Relation in Synchronous Thyroid Carcinomas Associated with Hashimoto’s Thyroiditis: A Next-Generation Sequencing Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

by
Vasiliki Kalliopi Bournia
1,†,
Iraklis Tsangaris
2,†,
Loukianos Rallidis
2,
Dimitrios Konstantonis
2,
Frantzeska Frantzeskaki
2,
Anastasia Anthi
2,
Stylianos E. Orfanos
2,
Eftychia Demerouti
3,
Panagiotis Karyofillis
3,
Vassilis Voudris
3,
Katerina Laskari
1,
Stylianos Panopoulos
1,
Panayiotis G. Vlachoyiannopoulos
4 and
Petros P. Sfikakis
1,*
1
First Department of Propaedeutic Internal Medicine and Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, 157 72 Athens, Greece
2
Pulmonary Hypertension Clinic, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 157 72 Athens, Greece
3
Invasive Cardiology Department, Onassis Cardiac Surgery Center, 176 74 Kallithea, Greece
4
Department of Pathophysiology and Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, 157 72 Athens, Greece
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Diagnostics 2020, 10(1), 49; https://doi.org/10.3390/diagnostics10010049
Submission received: 18 December 2019 / Revised: 15 January 2020 / Accepted: 16 January 2020 / Published: 19 January 2020

Abstract

Standard echocardiography is important for pulmonary arterial hypertension (PAH) screening in patients with connective tissue disease (CTD), but PAH diagnosis and monitoring require cardiac catheterization. Herein, using cardiac catheterization as reference, we tested the hypothesis that follow-up echocardiography is adequate for clinical decision-making in these patients. We prospectively studied 69 consecutive patients with CTD-associated PAH. Invasive baseline pulmonary artery systolic pressure (PASP) was 60.19 ± 16.33 mmHg (mean ± SD) and pulmonary vascular resistance (PVR) was 6.44 ± 2.95WU. All patients underwent hemodynamic and echocardiographic follow-up after 9.47 ± 7.29 months; 27 patients had a third follow-up after 17.2 ± 7.4 months from baseline. We examined whether clinically meaningful hemodynamic deterioration of follow-up catheterization-derived PASP (i.e., > 10% increase) could be predicted by simultaneous echocardiography. Echocardiography predicted hemodynamic PASP deterioration with 59% sensitivity, 85% specificity, and 63/83% positive/negative predictive value, respectively. In multivariate analysis, successful echocardiographic prediction correlated only with higher PVR in previous catheterization (p = 0.05, OR = 1.235). Notably, in patients having baseline PVR > 5.45 WU, echocardiography had both sensitivity and positive predictive values of 73%, and both specificity and negative predictive value of 91% for detecting hemodynamic PASP deterioration. In selected patients with CTD-PAH echocardiography can predict PASP deterioration with high specificity and negative predictive value. Additional prospective studies are needed to confirm that better patient selection can increase the ability of standard echocardiography to replace repeat catheterization.
Keywords: echocardiography; pulmonary arterial hypertension; systemic sclerosis; systemic lupus erythematosus; mixed connective tissue disease echocardiography; pulmonary arterial hypertension; systemic sclerosis; systemic lupus erythematosus; mixed connective tissue disease

Share and Cite

MDPI and ACS Style

Bournia, V.K.; Tsangaris, I.; Rallidis, L.; Konstantonis, D.; Frantzeskaki, F.; Anthi, A.; Orfanos, S.E.; Demerouti, E.; Karyofillis, P.; Voudris, V.; et al. Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. Diagnostics 2020, 10, 49. https://doi.org/10.3390/diagnostics10010049

AMA Style

Bournia VK, Tsangaris I, Rallidis L, Konstantonis D, Frantzeskaki F, Anthi A, Orfanos SE, Demerouti E, Karyofillis P, Voudris V, et al. Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. Diagnostics. 2020; 10(1):49. https://doi.org/10.3390/diagnostics10010049

Chicago/Turabian Style

Bournia, Vasiliki Kalliopi, Iraklis Tsangaris, Loukianos Rallidis, Dimitrios Konstantonis, Frantzeska Frantzeskaki, Anastasia Anthi, Stylianos E. Orfanos, Eftychia Demerouti, Panagiotis Karyofillis, Vassilis Voudris, and et al. 2020. "Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension" Diagnostics 10, no. 1: 49. https://doi.org/10.3390/diagnostics10010049

APA Style

Bournia, V. K., Tsangaris, I., Rallidis, L., Konstantonis, D., Frantzeskaki, F., Anthi, A., Orfanos, S. E., Demerouti, E., Karyofillis, P., Voudris, V., Laskari, K., Panopoulos, S., Vlachoyiannopoulos, P. G., & Sfikakis, P. P. (2020). Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. Diagnostics, 10(1), 49. https://doi.org/10.3390/diagnostics10010049

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop